---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-113413"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-10-08T23:59:59+00:00"
generated_at: "2026-05-30T18:06:24.589516+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Iterum shareholders approve authority to issue shares without pre-emptive rights at Oct 8 EGM

## Summary
- Proposal to allow board to allot shares for cash without offering to existing shareholders passed with 9,785,120 votes for, 3,103,525 against, 133,633 abstain.
- Approval required 75% of votes cast; threshold met with ~75.9% in favor.
- Authority provides flexibility for potential future capital raises without pre-emptive obligation.
- Matter considered routine under NYSE rules; no broker non-votes.

## SEC filing metadata
- accession: 0000950170-24-113413
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-10-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024113413/0000950170-24-113413-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024113413/itrm-20241008.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-113413
- JSON: https://secwatch.observer/filing/0000950170-24-113413.json
- Plain text: https://secwatch.observer/filing/0000950170-24-113413.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.